Profil
Patrick Flynn has worked as a Director at Common Sensing, Inc. since 2013 and is currently employed there.
He is also currently a Director at NeuroRx, Inc.
Aktive Positionen von Patrick Flynn
Unternehmen | Position | Beginn |
---|---|---|
NeuroRx, Inc.
NeuroRx, Inc. BiotechnologyHealth Technology NeuroRx, Inc. operates as a clinical stage, small molecule pharmaceutical company developing novel therapeutics for the treatment of central nervous system disorders. The company was founded by Jonathan C. Javitt and Daniel C. Javitt in 2015 and is headquartered in Wilmington, DE. | Direktor/Vorstandsmitglied | - |
Common Sensing, Inc.
Common Sensing, Inc. Medical SpecialtiesHealth Technology Common Sensing, Inc. engages in the provision of medical devices services. Its products includes the Gocap System, which utilizes a smart cap that automatically sends drug-delivery data from disposable pen-injectors to a mobile app. The company was founded by Richard Whalley and James White in September 2012 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 01.06.2013 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
NeuroRx, Inc.
NeuroRx, Inc. BiotechnologyHealth Technology NeuroRx, Inc. operates as a clinical stage, small molecule pharmaceutical company developing novel therapeutics for the treatment of central nervous system disorders. The company was founded by Jonathan C. Javitt and Daniel C. Javitt in 2015 and is headquartered in Wilmington, DE. | Health Technology |
Common Sensing, Inc.
Common Sensing, Inc. Medical SpecialtiesHealth Technology Common Sensing, Inc. engages in the provision of medical devices services. Its products includes the Gocap System, which utilizes a smart cap that automatically sends drug-delivery data from disposable pen-injectors to a mobile app. The company was founded by Richard Whalley and James White in September 2012 and is headquartered in Cambridge, MA. | Health Technology |